Free Trial

Alumis (ALMS) Competitors

Alumis logo
$4.02 +0.06 (+1.52%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$4.06 +0.04 (+1.00%)
As of 10/3/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALMS vs. TWST, COGT, BHVN, HRMY, PAHC, VCEL, AVDL, GPCR, SDGR, and ABCL

Should you be buying Alumis stock or one of its competitors? The main competitors of Alumis include Twist Bioscience (TWST), Cogent Biosciences (COGT), Biohaven (BHVN), Harmony Biosciences (HRMY), Phibro Animal Health (PAHC), Vericel (VCEL), Avadel Pharmaceuticals (AVDL), Structure Therapeutics (GPCR), Schrodinger (SDGR), and AbCellera Biologics (ABCL). These companies are all part of the "pharmaceutical products" industry.

Alumis vs. Its Competitors

Twist Bioscience (NASDAQ:TWST) and Alumis (NASDAQ:ALMS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Twist Bioscience presently has a consensus price target of $48.90, suggesting a potential upside of 57.39%. Alumis has a consensus price target of $20.17, suggesting a potential upside of 401.66%. Given Alumis' stronger consensus rating and higher possible upside, analysts clearly believe Alumis is more favorable than Twist Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Twist Bioscience
2 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.55
Alumis
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.89

Twist Bioscience has a beta of 2.38, meaning that its share price is 138% more volatile than the S&P 500. Comparatively, Alumis has a beta of -1.47, meaning that its share price is 247% less volatile than the S&P 500.

Twist Bioscience has higher revenue and earnings than Alumis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Twist Bioscience$312.97M5.99-$208.73M-$1.45-21.43
AlumisN/AN/A-$294.23MN/AN/A

In the previous week, Twist Bioscience had 2 more articles in the media than Alumis. MarketBeat recorded 4 mentions for Twist Bioscience and 2 mentions for Alumis. Alumis' average media sentiment score of 1.66 beat Twist Bioscience's score of 0.22 indicating that Alumis is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Twist Bioscience
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alumis
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Alumis has a net margin of 0.00% compared to Twist Bioscience's net margin of -23.51%. Twist Bioscience's return on equity of -29.03% beat Alumis' return on equity.

Company Net Margins Return on Equity Return on Assets
Twist Bioscience-23.51% -29.03% -21.77%
Alumis N/A -119.15%-92.50%

Summary

Twist Bioscience beats Alumis on 7 of the 12 factors compared between the two stocks.

Get Alumis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALMS vs. The Competition

MetricAlumisMED IndustryMedical SectorNASDAQ Exchange
Market Cap$418.34M$3.36B$6.13B$10.58B
Dividend YieldN/A2.28%5.65%4.69%
P/E RatioN/A22.2886.9626.71
Price / SalesN/A458.33604.82131.77
Price / CashN/A47.8637.9061.31
Price / Book0.739.9312.556.55
Net Income-$294.23M-$52.80M$3.31B$277.50M
7 Day Performance-0.74%5.22%4.28%2.42%
1 Month Performance-10.86%10.61%6.90%8.63%
1 Year Performance-58.73%25.03%70.54%31.60%

Alumis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALMS
Alumis
3.7169 of 5 stars
$4.02
+1.5%
$20.17
+401.7%
-58.7%$418.34MN/A0.00N/ANews Coverage
Positive News
TWST
Twist Bioscience
3.7033 of 5 stars
$26.89
+0.5%
$49.40
+83.7%
-28.3%$1.62B$312.97M-18.55990Analyst Forecast
COGT
Cogent Biosciences
2.686 of 5 stars
$14.14
+6.4%
$20.00
+41.5%
+41.9%$1.61BN/A-7.9480
BHVN
Biohaven
3.1809 of 5 stars
$14.98
+8.4%
$48.85
+226.0%
-66.8%$1.59BN/A-1.96239Positive News
HRMY
Harmony Biosciences
4.6587 of 5 stars
$27.53
+1.8%
$45.50
+65.3%
-21.2%$1.58B$714.73M8.88200
PAHC
Phibro Animal Health
4.5778 of 5 stars
$38.84
+2.1%
$28.40
-26.9%
+79.8%$1.57B$1.30B32.922,475Positive News
VCEL
Vericel
3.1551 of 5 stars
$30.23
+1.3%
$60.40
+99.8%
-25.2%$1.53B$237.22M251.96300Positive News
AVDL
Avadel Pharmaceuticals
3.128 of 5 stars
$15.34
+0.1%
$20.86
+35.9%
+14.7%$1.49B$169.12M-511.4770
GPCR
Structure Therapeutics
3.1311 of 5 stars
$25.03
+0.1%
$68.67
+174.4%
-36.5%$1.44BN/A-23.83136
SDGR
Schrodinger
3.3813 of 5 stars
$19.29
+1.4%
$27.83
+44.3%
+17.6%$1.42B$207.54M-7.78790News Coverage
Analyst Downgrade
ABCL
AbCellera Biologics
3.2024 of 5 stars
$4.75
+2.0%
$8.00
+68.6%
+136.0%$1.42B$28.83M-8.63500News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:ALMS) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners